← Eichor
Study identifier: NCT05936814 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Adductor Ratio in Severe Varus Gonarthrosis

Condition: Osteoarthritis, Knee · Genu Varum · Joint Prosthesis; Complications  ·  Sponsor: Saglik Bilimleri Universitesi

PhaseN/A
Planned participants68
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersNo

About this study

The restoration of the joint line (JL) is essential for the proper functioning of Total Knee Arthroplasty (TKA). The exact position of JL can be determined using anatomical landmarks such as femoral condylar width (TEW), tibial tubercle, fibular head, and adductor tubercle during preoperative planning or intraoperatively. However, in cases of severe varus deformity in Type M gonarthrosis, it is unknown which method is most suitable for accurately determining the precise JL position. The aim of this study is to identify the most appropriate method for determining the JL position in Type M gonarthrosis. To achieve this goal, two groups of patients with Type 1A and Type M gonarthrosis will be compared by measuring preoperative values and comparing them with intraoperative reference values.

This description comes directly from the study's public registry record.

Talk to the study team

süheyla atay  ·  00902167778777  ·  suheylaatay81@gmail.com

bülent karslıoğlu  ·  00905058106373

Always discuss trial participation with your own doctor first.

Locations (1)

Keçiören SUAMAnkara, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05936814